The presence of diabetes does not influence clinical outcomes in patients with community-acquired pneumonia: results from the community-acquired pneumonia organization (CAPO) international cohort study

P. Fernandez, P. Jimenez, P. Peyrani, J. Ramirez (Santiago, Chile; Louisville, KY, United States Of America)

Source: Annual Congress 2007 - Severity scores and comorbidities in community-acquired pneumonia

Session: Severity scores and comorbidities in community-acquired pneumonia
Session type: Oral Presentation
Number: 424

Disease area: Respiratory infections

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Fernandez, P. Jimenez, P. Peyrani, J. Ramirez (Santiago, Chile; Louisville, KY, United States Of America). The presence of diabetes does not influence clinical outcomes in patients with community-acquired pneumonia: results from the community-acquired pneumonia organization (CAPO) international cohort study. Eur Respir J 2007; 30: Suppl. 51, 424

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Mortality directly related to community-acquired pneumonia (CAP) in hospitalized patients: results from the community-acquired pneumonia organization (CAPO) international cohort study Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia Year: 2007
Significant decrease in long-term survival for hospitalised patients with community-acquired pneumonia (CAP): results from the community-acquired pneumonia organisation (CAPO) international cohort study Source: Annual Congress 2009 - Impact of biomarkers in the management of community-acquired pneumonia Year: 2009
Thrombocytosis predicts poor outcomes in patients with community-acquired pneumonia: results from the CAPO international cohort study Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections Year: 2008
Female gender is associated with poor clinical outcomes in hospitalized patients with community-acquired pneumonia: results from the CAPO international cohort study Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia Year: 2008
A worldwide perspective of the level of compliance with guidelines in hospitalized patients with community-acquired pneumonia: results from the CAPO cohort international study Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia Year: 2008
The presence of diabetes mellitus does not influence clinical outcomes in patient with community-acquired pneumonia: Results from the CAPO international cohort study Source: Annual Congress 2010 - Risk factors and outcomes in community-acquired pneumonia Year: 2010
Patients‘ characteristics do not influence duration of antibiotic therapy (ABT) in hospitalized patients with community-acquired pneumonia (CAP): results from the CAPO international study Source: Annual Congress 2008 - Treatment and outcome in hospitalised patients with community-acquired pneumonia Year: 2008
Community-acquired pneumonia in the elderly: Spanish multicentre study Source: Eur Respir J 2003; 21: 294-302 Year: 2003
The pneumonia severity index (PSI) do not underestimate the severity of community-acquired pneumonia (CAP) in young patients: results from the CAPO international study Source: Annual Congress 2008 - Factors related to outcome of community-acquired pneumonia Year: 2008
Another view on the prediction of outcomes in patients with community-acquired pneumonia Source: Eur Respir J 2011; 38: 991-992 Year: 2011
Another view on the prediction of outcomes in patients with community-acquired pneumonia Source: Eur Respir J 2011; 38: 992-993 Year: 2011
Epidemiology and outcomes in hospitalized patients with health-care-associated pneumonia (HCAP) and community-acquired pneummonia (CAP)~ A prospective observational cohort analysis Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia Year: 2009
The impact of adherence to guidelines for hospitalized community-acquired pneumonia on health outcomes and mortality: A retrospective cohort study Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015
The impact of hyperglycemia on community-acquired pneumonia: A retrospective cohort study Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016
Pleural effusion predicts poor outcomes in hospitalized patients with community-acquired pneumonia: results from the CAPO international cohort study Source: Annual Congress 2008 - Community-acquired pneumonia: prognosis, complications and prevention Year: 2008
Clinical outcomes of HIV-infected patients hospitalized with community-acquired pneumonia: Results from CAPO international cohort study Source: Annual Congress 2010 - Risk factors and outcomes in community-acquired pneumonia Year: 2010
Timing of previous hospitalizations impacts outcomes in hospitalized patients with community-acquired pneumonia (CAP) Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia Year: 2009
Steroids are not associated with an improvement in clinical outcomes in hospitalized patients with community-acquired pneumonia (CAP) Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections Year: 2009
Do not resuscitat orders in community-acquired pneumonia: a restrospective cohort study. Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers Year: 2017
Implementation of severity guided antibiotic treatment according to Dutch guidelines in hospitalized patients with community-acquired pneumonia (CAP) included in a clinical trial Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections Year: 2011